TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30188495

Group type: EXPERIMENTAL
Intervention: Wrist cooling (cool[on])
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (control[off])
Number of subjects: 11
Study: 26709933

Group type: EXPERIMENTAL
Intervention: Isoflurane at 1.5 times the MAC
Number of subjects: 8

Group type: COMPARATOR
Intervention: Isoflurane at 2.0 times the MAC
Number of subjects: 8
Study: 25144437

Group type: EXPERIMENTAL
Intervention: PNF (2 series of contract‐relax stretching)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: SS (static stretching for 1 min)
Number of subjects: 70
Study: 21916989

Group type: EXPERIMENTAL
Intervention: 10-day sequential therapy (20 mg rabeprazole and 1 g amoxicillin, twice daily for the first 5 days, followed by 20 mg rabeprazole, 500 mg clarithromycin, and 500 mg metronidazole, twice daily for the remaining 5 days)
Number of subjects: 246

Group type: COMPARATOR
Intervention: 7-day triple therapy (20 mg rabeprazole, 500 mg clarithromycin, and 1 g amoxicillin, twice daily for 7 days)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Both therapy groups
Number of subjects: 246
Study: 19533009

Group type: EXPERIMENTAL
Intervention: Incontinence pessary
Number of subjects: 266

Group type: COMPARATOR
Intervention: Behavioral therapy
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Both incontinence pessary and behavioral therapy
Number of subjects: 266
Study: 17601803

Group type: EXPERIMENTAL
Intervention: modified constraint-induced movement therapy (mCIMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: traditional rehabilitation (TR)
Number of subjects: 30
Study: 15465623

Group type: EXPERIMENTAL
Intervention: Mitochondrial complex I mutations in PD
Number of subjects: 0
Study: 12177587

Group type: EXPERIMENTAL
Intervention: High-dose amisulpride (ASP)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Flupentixol (FPX)
Number of subjects: 126
Study: 10373140

Group type: EXPERIMENTAL
Intervention: Dual therapy (omeprazole 1 mg/kg/day and amoxicillin 50 mg/kg; maximum, 2 g/day)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Triple therapy (omeprazole 1 mg/kg/day or 2 mg/kg/day, amoxicillin 50 mg/kg; maximum, 2 g/day, and clarithromycin 20 mg/kg; maximum, 1 g/day)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Omeprazole (1 mg/kg/day or 2 mg/kg/day)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Rapid urease test
Number of subjects: 252

Group type: COMPARATOR
Intervention: 13C‐urea breath test
Number of subjects: 252
Study: 7888256

Group type: EXPERIMENTAL
Intervention: Cold air inhalation during exercise testing
Number of subjects: 12

Group type: COMPARATOR
Intervention: Room air during exercise testing
Number of subjects: 12
Study: 2091873

Group type: EXPERIMENTAL
Intervention: Genapol stabilized human insulin (HOE 21 PH H‐TRONIN)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Neutral preparation of biosynthetic human insulin (BHI)
Number of subjects: 21
Study: 319641

Group type: EXPERIMENTAL
Intervention: Timolol maleate
Number of subjects: 309

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309
Study: 30914385

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (40 IU, 100 IU, 160 IU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28290994

Group type: EXPERIMENTAL
Intervention: Long DAPT duration (12–24 months)
Number of subjects: 14963

Group type: COMPARATOR
Intervention: Short DAPT duration (3–6 months)
Number of subjects: 14963

Group type: EXPERIMENTAL
Intervention: PRECISE-DAPT score
Number of subjects: 14963
Study: 25679344

Group type: EXPERIMENTAL
Intervention: 1-mA current, 1-mm probe depth
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 1-mA current, 4-mm probe depth
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 2-mA current, 1-mm probe depth
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 2-mA current, 4-mm probe depth
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 1-mA intensity
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 2-mA intensity
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 1-mm probe depth
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 2-mA current
Number of subjects: 64
Study: 22434361

Group type: EXPERIMENTAL
Intervention: CPAP at 15 cm H(2)O
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Theoretical prediction of CBF change
Number of subjects: 23
Study: 21289226

Group type: EXPERIMENTAL
Intervention: Vitamin D-fortified yogurt drink (DY; containing 500 IU vitamin D(3) and 150 mg Ca/250 mL)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Vitamin D + calcium-fortified yogurt drink (DCY; containing 500 IU vitamin D(3) and 250 mg Ca/250 mL)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Plain yogurt drink (PY; containing no vitamin D and 150 mg Ca/250 mL)
Number of subjects: 90
Study: 19337745

Group type: EXPERIMENTAL
Intervention: Acetazolamide 125 mg (ACZ)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sildenafil 40 mg (SIL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 15
Study: 17080879

Group type: EXPERIMENTAL
Intervention: One‐Up Bond F Plus (Tokuyama Dental)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adper Prompt L‐Pop (3M ESPE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no saliva contamination)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Re-application of adhesives after drying or rinsing saliva
Number of subjects: 0
Study: 15623613

Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 15370949

Group type: EXPERIMENTAL
Intervention: Enhanced psychiatric case management (PCM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 20
Study: 10510926

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 3040

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3040
Study: 7552182

Group type: EXPERIMENTAL
Intervention: Pretreatment protocol A (within 12 hours before IRCM)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Pretreatment protocol B (for 72 hours before IRCM)
Number of subjects: 45
Study: 2123559

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6273028

Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D3 (mean dose 0.5 microgram daily)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: D3 (dose 100 microgram daily)
Number of subjects: 17
Study: 31046700

Group type: EXPERIMENTAL
Intervention: PEG‐IFN alfa‐2b 1.0 μg/kg/wk for 24 weeks
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: PEG‐IFN alfa‐2b 1.5 μg/kg/wk for 24 weeks
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: PEG‐IFN alfa‐2b 1.5 μg/kg/wk for 48 weeks
Number of subjects: 322

Group type: COMPARATOR
Intervention: No further NA treatment after EOS
Number of subjects: 322
Study: 28538361

Group type: EXPERIMENTAL
Intervention: PVO-associated SND
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: High Charlson index
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Low ASIA impairment scale at diagnosis
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Thoracic spinal cord compression
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Epidural abscess
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Cervical involvement
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Thoracic involvement
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Staphylococcus aureus PVO
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: CRP >150 mg/L
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Duration of antibiotic treatment
Number of subjects: 394
Study: 25856469

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (500 mg/d)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 23479383

Group type: EXPERIMENTAL
Intervention: Cetuximab plus concomitant boost radiotherapy
Number of subjects: 22
Study: 21849598

Group type: EXPERIMENTAL
Intervention: 2 portions of farmed salmon/wk
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (habitual diet)
Number of subjects: 123
Study: 18800142

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Conventional anti-hypertensive treatment
Number of subjects: 3000
Study: 17923541

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide drops applied 3 times a day for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo drops applied 3 times a day for 4 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dorzolamide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15519794

Group type: EXPERIMENTAL
Intervention: Orgotein for 7 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 100
Study: 11305153

Group type: EXPERIMENTAL
Intervention: Laparoscopic fundoplication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fundoplication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional open fundoplication
Number of subjects: 0
Study: 9773780

Group type: EXPERIMENTAL
Intervention: Smoking two cigarettes
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nicotine-containing chewing gum
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Smoking in patients with IgA glomerulonephritis
Number of subjects: 22

Group type: COMPARATOR
Intervention: Smoking in all volunteers (n=35) vs patients (n=7)
Number of subjects: 22
Study: 7836707

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin, 4000 U daily SQ for 7-20 days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin
Number of subjects: 19
Study: 31655965

Group type: EXPERIMENTAL
Intervention: Robot-based play-drama intervention
Number of subjects: 23

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 23
Study: 30534176

Group type: EXPERIMENTAL
Intervention: Osteopathic visceral manipulation (OVM); treatment group (OVMG)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo visceral manipulation (PVM); control group (PVMG)
Number of subjects: 28
Study: 27906935

Group type: EXPERIMENTAL
Intervention: Prednisolone 10 mg daily (group I)
Number of subjects: 58

Group type: COMPARATOR
Intervention: No prednisolone (group II)
Number of subjects: 58
Study: 23984946

Group type: EXPERIMENTAL
Intervention: Reactivation during sleep
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sleep without reactivation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer sleep time
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional reactivation by cueing during sleep
Number of subjects: 0
Study: 22720283

Group type: EXPERIMENTAL
Intervention: Converted implant‐retained overdenture (IOD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Relined conventional denture (RCD)
Number of subjects: 60
Study: 20072064

Group type: EXPERIMENTAL
Intervention: Ascending back squat protocol (5 reps at 30% 1RM, 3 reps at 70% 1RM, 3 reps at 90% 1RM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control session (rest for 5 minutes before horizontal plyometric tests)
Number of subjects: 12
Study: 19058074

Group type: EXPERIMENTAL
Intervention: Physician's screening recommendation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fewer barriers, better knowledge, and more positive beliefs toward screening
Number of subjects: 0
Study: 16331116

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/day
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Felodipine extended release 5 mg/day
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 12827099

Group type: EXPERIMENTAL
Intervention: Home Communication Intervention (HCI)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Routine Care
Number of subjects: 35
Study: 10636511

Group type: EXPERIMENTAL
Intervention: Raloxifene 30, 60, or 150 mg per day
Number of subjects: 969

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 969
Study: 8833216

Group type: EXPERIMENTAL
Intervention: Nasal salmon calcitonin (SCT) 200 IU
Number of subjects: 62

Group type: COMPARATOR
Intervention: Nasal placebo
Number of subjects: 62
Study: 1568586

Group type: EXPERIMENTAL
Intervention: Sclerotherapy plus propranolol (group 2)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sclerotherapy alone (group 1)
Number of subjects: 75
Study: 3926567

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional insulin treatment (CIT)
Number of subjects: 70
Study: 30780194

Group type: COMPARATOR
Intervention: Half-dose clarithromycin group (esomeprazole 20 mg bid, amoxicillin 1 g bid, clarithromycin 250 mg bid, bismuth potassium citrate 0.6 g bid) for 14 days
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Standard-dose clarithromycin group (esomeprazole 20 mg bid, amoxicillin 1 g bid, clarithromycin 500 mg bid, bismuth potassium citrate 0.6 g bid) for 14 days
Number of subjects: 210
Study: 29226355

Group type: EXPERIMENTAL
Intervention: Low working memory in Grade 1
Number of subjects: 1802

Group type: COMPARATOR
Intervention: Grade 1 low working memory
Number of subjects: 1802

Group type: EXPERIMENTAL
Intervention: Standard scores for verbal, visuospatial, and overall working memory
Number of subjects: 1802
Study: 26599039

Group type: EXPERIMENTAL
Intervention: Red wine polyphenols
Number of subjects: 10

Group type: COMPARATOR
Intervention: De-alcoholized red wine
Number of subjects: 10
Study: 25070960

Group type: EXPERIMENTAL
Intervention: Terutroban
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Comparison of Terutroban and Aspirin
Number of subjects: 1141
Study: 23131115

Group type: EXPERIMENTAL
Intervention: M5 EBM (one-semester EBM course)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: M6 (exposed to EBM instruction during the previous year)
Number of subjects: 289

Group type: COMPARATOR
Intervention: M5 non-EBM (control group)
Number of subjects: 289

Group type: COMPARATOR
Intervention: M4 (not yet exposed)
Number of subjects: 289
Study: 20946740

Group type: EXPERIMENTAL
Intervention: Alcohol-specific support (measured by network drinking and opposition to patient drinking)
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Other measures of network support
Number of subjects: 1373
Study: 18035006

Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil group (n=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Etomidate-remifentanil group (n=25)
Number of subjects: 50
Study: 16217243

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Selenium
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Vitamin E and Selenium (combination)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 12048320

Group type: EXPERIMENTAL
Intervention: Endurance-trained men
Number of subjects: 20
Study: 9456279

Group type: EXPERIMENTAL
Intervention: sotalol, 120 mg daily (n = 93)
Number of subjects: 191

Group type: COMPARATOR
Intervention: metoprolol, 75 mg daily (n = 98)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: sotalol
Number of subjects: 191
Study: 7615283

Group type: EXPERIMENTAL
Intervention: Real time, electromagnetic imaging system (imager view)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard colonoscopy (without imager view)
Number of subjects: 55
Study: 2240092

Group type: EXPERIMENTAL
Intervention: Continuous closure (201 patients)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Interrupted en bloc (201 patients)
Number of subjects: 402
Study: 708547

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (lumbar extradural blockade)
Number of subjects: 32
Study: 31498125

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 146

Group type: COMPARATOR
Intervention: Physical exercise training
Number of subjects: 146

Group type: COMPARATOR
Intervention: Mindfulness practice
Number of subjects: 146

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 146
Study: 27258204

Group type: EXPERIMENTAL
Intervention: Oral acetylsalicylic acid 100 mg per day after dinner
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (PICC maintain technique only)
Number of subjects: 96
Study: 26514213

Group type: COMPARATOR
Intervention: Waxy maize starch (WMS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Waxy maize starch and whey protein (WMS+WP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistant starch (RS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistant starch and whey protein (RS+WP)
Number of subjects: 0
Study: 22546942

Group type: EXPERIMENTAL
Intervention: SRP + PT (single session of adjunctive phototherapy)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: SRP + rPT (repeated sessions of adjunctive phototherapy)
Number of subjects: 27

Group type: COMPARATOR
Intervention: SRP (control group)
Number of subjects: 27
Study: 20721930

Group type: EXPERIMENTAL
Intervention: FRAX calculator with baseline BMD
Number of subjects: 1422

Group type: EXPERIMENTAL
Intervention: FRAX calculator without baseline BMD
Number of subjects: 1422

Group type: EXPERIMENTAL
Intervention: Garvan calculator
Number of subjects: 1422

Group type: COMPARATOR
Intervention: Models using only age and BMD
Number of subjects: 1422
Study: 18985633

Group type: EXPERIMENTAL
Intervention: End-to-end anastomosis
Number of subjects: 77

Group type: COMPARATOR
Intervention: End-to-side anastomosis
Number of subjects: 77
Study: 17679249

Group type: EXPERIMENTAL
Intervention: Nicotine transdermal patch
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study: 15247755

Group type: EXPERIMENTAL
Intervention: 1% testosterone gel (T-gel)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 75
Study: 11772480

Group type: EXPERIMENTAL
Intervention: Self-report (SR) plus breath carbon monoxide (CO) monitoring
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Self-report (SR) plus urine cotinine (COT) analysis
Number of subjects: 200

Group type: COMPARATOR
Intervention: Nonsmoking self-reports
Number of subjects: 200
Study: 9439492

Group type: EXPERIMENTAL
Intervention: sICAM‐1 concentrations in the highest quartile (> 260 ng/mL)
Number of subjects: 14916

Group type: EXPERIMENTAL
Intervention: sICAM‐1 concentrations in the highest quartile
Number of subjects: 14916

Group type: COMPARATOR
Intervention: sICAM‐1 concentrations
Number of subjects: 14916
Study: 8120405

Group type: EXPERIMENTAL
Intervention: 1 microgram rhu IL-1R
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 10 micrograms rhu IL-1R
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 25 micrograms rhu IL-1R
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 50 micrograms rhu IL-1R
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 100 micrograms rhu IL-1R
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2568824

Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment for three to four months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo baseline
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment
Number of subjects: 62

Group type: COMPARATOR
Intervention: Drug-free baseline
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Positive syndrome
Number of subjects: 62
Study: 357309

Group type: EXPERIMENTAL
Intervention: Initial trials on a limited number of patients for specific disease control or prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled clinical studies of antirheumatic and antianginal drugs
Number of subjects: 0
Study: 28957795

Group type: EXPERIMENTAL
Intervention: Rasahara and Yoga
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 157

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 157
Study: 27267551

Group type: EXPERIMENTAL
Intervention: Voluntary exercise program (EX-group)
Number of subjects: 125

Group type: COMPARATOR
Intervention: No exercise (NoEX-group)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: EX-group
Number of subjects: 125
Study: 25146491

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus HN001
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp lactis HN019
Number of subjects: 331

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study: 22487079

Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump system
Number of subjects: 131

Group type: COMPARATOR
Intervention: Conventional insulin pump therapy
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Frequent sensor use
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Irregular or no sensor use
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Daily insulin requirements
Number of subjects: 131
Study: 20099953

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 200

Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 200
Study: 18578564

Group type: EXPERIMENTAL
Intervention: 23-minute video intervention depicting couples overcoming barriers to safer sexual behaviors
Number of subjects: 38635

Group type: COMPARATOR
Intervention: Standard waiting room environment (control)
Number of subjects: 38635

Group type: EXPERIMENTAL
Intervention: 23-minute video intervention
Number of subjects: 38635
Study: 15892085

Group type: EXPERIMENTAL
Intervention: Adacolumn® treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: G-1 beads (in vitro)
Number of subjects: 6
Study: 12538276

Group type: EXPERIMENTAL
Intervention: Arch-first technique (group A)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional technique (group B)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 10862528

Group type: COMPARATOR
Intervention: Walking (low intensity)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Weights (high intensity strength training)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: WeightsHRT (high intensity strength training with HRT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: WalkingHRT (low intensity walking with HRT)
Number of subjects: 64